SHIKARI® Q-CERT


Enzyme immunoassay for the quantitative determination of Certolizumab(CIMZIA®) in human serum and plasma

Enzyme immunoassay for the quantitative determination of Certolizumab(CIMZIA®) in serum and plasma. The Matriks Biotek Shikari Q-CERT ELISA has been especially developed for the quantitative analysis of free Certolizumab in serum and plasma samples.



Click the diagram to see bigger



Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 12
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Intl.calls&Whatsapp: +90 (546) 485 42 94
Email: info@matriksbiotek.com
Email: order@matriksbiotek.com
Fax: +90 (312) 485 11 87